MoneyWorks4Me

Mankind Pharma - Quaterly Results

31 Jul 2026 Evaluate
The June 2026 quarter revenue stood at Rs. 29640.50 millions, up 15.34% as compared to Rs. 25697.30 millions during the corresponding quarter last year.A comparatively good net profit growth of 34.49% to Rs. 5584.90 millions was reported for the quarter ended June 2026 compared to Rs. 4152.70 millions of previous same quarter.The company reported a good operating profit of 9625.40 millions compared to 7501.40 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 29640.50 25697.30 15.34 29640.50 25697.30 15.34 104211.80 95074.10 9.61
Other Income 339.60 652.10 -47.92 339.60 652.10 -47.92 3261.00 4934.20 -33.91
PBIDT 9625.40 7501.40 28.31 9625.40 7501.40 28.31 34120.20 29182.40 16.92
Interest 949.50 1493.40 -36.42 949.50 1493.40 -36.42 5622.10 3769.80 49.14
PBDT 8675.90 6008.00 44.41 8675.90 6008.00 44.41 27435.70 25412.60 7.96
Depreciation 1110.20 1046.30 6.11 1110.20 1046.30 6.11 4285.70 3947.60 8.56
PBT 7565.70 4961.70 52.48 7565.70 4961.70 52.48 23150.00 21465.00 7.85
TAX 1980.80 809.00 144.85 1980.80 809.00 144.85 2774.40 4217.40 -34.22
Deferred Tax 327.40 -112.40 -391.28 327.40 -112.40 -391.28 -1957.80 -481.90 306.27
PAT 5584.90 4152.70 34.49 5584.90 4152.70 34.49 20375.60 17247.60 18.14
Equity 413.00 412.70 0.07 413.00 412.70 0.07 412.80 412.60 0.05
PBIDTM(%) 32.47 29.19 11.24 32.47 29.19 11.24 32.74 30.69 6.67
Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..